Comprehensive Test Bank for Pharmacology and the Nursing Process, 9th Edition by Linda Lane Lilley, Shelly Rainforth Collins, and Julie S. Snyder

Comprehensive Test Bank for Pharmacology
and the Nursing Process, 9th Edition by Linda
Lane Lilley, Shelly Rainforth Collins, and Julie
S. Snyder


FDA Testing of OTC Drugs - ANSWER//OTCs are not
always FDA tested before approval. Adverse Effects -
ANSWER//Negative reactions that can occur with any
medication. Medication Administration Knowledge -
ANSWER//Understanding necessary for effective and safe
drug use. General Drug Information - ANSWER//Basic
knowledge required for medication management.
Pharmacologic Therapy - ANSWER//Current treatments;
requires updates every five years. Patient Education -
ANSWER//Nurses must inform patients about medication
risks. Drug Classification - ANSWER//Grouping of
medications based on similar properties. Researching
New Drugs - ANSWER//Nurses must stay informed about
unfamiliar medications. Medication Familiarity -
ANSWER//Nurses tend to know frequently administered
drugs. Patient Discharge Planning - ANSWER//Includes
instructions on safe OTC drug use. Serious Harm from
OTCs - ANSWER//Potential risks exist if OTCs are
misused. Medication Administration Risks - ANSWER//All
medications can have adverse effects. Pharmacology
Changes - ANSWER//New drugs and uses emerge
regularly. FDA - ANSWER//Agency regulating drug
approval and safety. OTC education - ANSWER//Patient
education on over-the-counter medications. Drug guide -
ANSWER//Resource providing nursing implications and
drug information. Lippincott's Nursing Drug Guide -
ANSWER//Alphabetical drug monographs for nursing use.
Drug Facts and Comparisons - ANSWER//Reference for
essential drug information. Physicians' Drug Reference
(PDR) - ANSWER//Comprehensive drug information for
healthcare providers. Nursing implications -

,ANSWER//Considerations for patient care related to
medications. Patient teaching points - ANSWER//Key
information for patients about their medications. Multidose
bottle - ANSWER//Container holding multiple doses of
medication. Drug label - ANSWER//Information source
including drug name and details. Expiration date -
ANSWER//Date indicating when a drug is no longer
effective. Concentration of drug - ANSWER//Amount of
active ingredient in a medication. Pharmacotherapeutic
level - ANSWER//Study of drug effects on the body.
Adverse effects - ANSWER//Negative or unexpected
reactions to medications. Teratogenic effects -
ANSWER//Adverse effects on fetal development from
drugs. Toxic effects - ANSWER//Harmful effects resulting
from excessive drug dosage. Chemical pharmacology -
ANSWER//Study of drug chemical properties and actions.
Molecular pharmacology - ANSWER//Study of drug
interactions at the molecular level. Impact of drugs -
ANSWER//Effects drugs have on bodily functions. Body's
response to drugs - ANSWER//Physiological reactions
following drug administration. Drug package insert -
ANSWER//Official document detailing drug usage and
information. Nurse's priority action - ANSWER//Safest
response when drug label is unreadable. Patient safety -
ANSWER//Preventing harm during medication
administration. Toxic effects - ANSWER//Negative
reactions from excessive medication dosages.
Therapeutic effects - ANSWER//Desired outcomes for
prescribed medications. Drug effects - ANSWER//Impact
of medication on the body. Allergies - ANSWER//Adverse
immune responses to substances. Pregnancy -
ANSWER//Condition affecting medication safety and
effects. Preexisting conditions - ANSWER//Health issues
present before medication administration. Nurse's drug
guide - ANSWER//Reference for medication information
and guidelines. Recent reference source - ANSWER//Up-
to-date information for medication safety. Pharmacist

,verification - ANSWER//Confirming medication information
with a pharmacist. Medication teaching -
ANSWER//Educating patients about their drug regimen.
Home medication self-administration - ANSWER//Patient
managing their own medications at home. FDA -
ANSWER//Agency regulating drug testing and approval.
DEA - ANSWER//Agency controlling the use of controlled
substances. CDC - ANSWER//Agency monitoring
infectious diseases. JCAHO - ANSWER//Accrediting body
for healthcare facilities. Phase I drug studies -
ANSWER//Initial trials assessing drug safety in humans.
Adverse effects - ANSWER//Unintended harmful reactions
to medications. Medication regimen - ANSWER//Schedule
and instructions for taking medications. Patient discharge
preparation - ANSWER//Instructions given to patients
before leaving healthcare. Medication safety -
ANSWER//Practices ensuring safe medication use.
Medication labeling - ANSWER//Proper identification and
instructions for medications. Controlled substances -
ANSWER//Drugs regulated due to potential for abuse.
Scientific testing - ANSWER//Rigorous evaluation of drug
efficacy and safety. JCAHO - ANSWER//Accrediting body
for acute care facility standards. Phase I drug studies -
ANSWER//Initial testing phase primarily involving healthy
males. Reproductive age women - ANSWER//Women of
childbearing age at risk during trials. Adverse effects -
ANSWER//Negative reactions to medications differing by
gender. Preclinical phase - ANSWER//Drug testing phase
conducted exclusively on animals. Phase III studies -
ANSWER//Final testing phase before drug market release.
Informed consent - ANSWER//Agreement acknowledging
risks before trial participation. Fetal damage -
ANSWER//Potential harm to unborn child from drug
exposure. Drug availability - ANSWER//Drugs in
preclinical phase are not patient-accessible.
Pharmaceutical companies - ANSWER//Entities that
develop and test new medications. FDA -

, ANSWER//Regulatory body overseeing drug safety and
efficacy. Underreporting - ANSWER//Pharmaceutical
companies may minimize reported drug issues. Clinical
market - ANSWER//Phase III phase where drugs are
widely used. Unexpected adverse effects -
ANSWER//New side effects discovered post-market
release. Drug recall - ANSWER//Withdrawal of a drug from
the market due to safety. Healthy young men -
ANSWER//Typical volunteer demographic for Phase I
studies. Risk assessment - ANSWER//Evaluating drug
benefits against potential adverse effects. Birth defects -
ANSWER//Congenital abnormalities potentially caused by
drug exposure. Drug testing rationale - ANSWER//Need
for gender-inclusive studies to ensure safety. Drug
monitoring - ANSWER//Ongoing observation of patients
receiving new medications. Phase II studies -
ANSWER//Testing phase focused on effectiveness and
side effects. Clinical trials - ANSWER//Research studies
assessing new drugs on human subjects. Drug approval
process - ANSWER//Regulatory steps before a medication
can be prescribed. Pharmaceutical Companies -
ANSWER//Profit motives are secondary to patient safety
concerns. FDA - ANSWER//Evaluates risk versus benefit
for drug testing phases. Adverse Effects -
ANSWER//Serious side effects can lead to market
removal. Telephone Triage Nurse - ANSWER//Assesses
patient needs via phone consultations. Narcotic
Prescription - ANSWER//Must be written, not called in to
pharmacies. Drug Enforcement Agency (DEA) -
ANSWER//Regulates controlled substances and addiction
risks. Controlled Substances - ANSWER//Regulated by
FDA and DEA for safety. CDC - ANSWER//Regulates
controlled substances to minimize injury risks. Schedule I
Medications - ANSWER//No accepted medical use; not
prescribed. Schedule V Medications - ANSWER//Lowest
abuse potential; some available over-the-counter.
Category A Drugs - ANSWER//No known risk; considered